Sudeep Pharma has released IPO and all details of IPO such as last date to apply, price, prospectus PDF and all other details are given below.
Sudeep Pharma IPO Details
| IPO Open Date | November 21, 2025 |
| IPO Close Date | November 25, 2025 |
| Face Value | ₹1 Per Equity Share |
| IPO Price Band | ₹563 to ₹593 Per Share |
| Issue Size | Approx ₹895 Crores |
| Fresh Issue | Approx ₹95.00 Crores |
| Offer for Sale | Approx 1,34,90,726 Equity Shares |
| Issue Type | Book build Issue |
| IPO Listing | BSE, NSE |
| Download Prospectus PDF | Click Here |
Sudeep Pharma IPO Dates and Schedule
| IPO Open Date | November 21, 2025 |
| IPO Close Date | November 25, 2025 |
| Basis of Allotment | November 26, 2025 |
| Refunds | November 27, 2025 |
| Credit to Demat Account | November 27, 2025 |
| IPO Listing Date | November 28, 2025 |
| IPO Bidding Cut-off Time | November 25, 2025 – 5 PM |
About Sudeep Pharma IPO
Sudeep Pharma Limited, established in 1989, is a company that manufactures pharmaceutical excipients, food-grade minerals, and specialty nutrition ingredients. It supplies its products to more than 100 countries. The company operates six manufacturing units with a total production capacity of 50,000 MT. Its main focus is on minerals like calcium, iron, magnesium, zinc, potassium, and sodium. It offers over 200 products to customers in the pharmaceutical, food, and nutrition industries. The company also has strong research and development facilities with in-house labs and pilot-scale setups that work mainly on mineral salts and excipients. Its product range includes pharmaceutical, food and nutrition products, specialty ingredients, and triturates. As of December 31, 2024, Sudeep Pharma Limited had 704 permanent employees. The company’s key strengths include market leadership with a wide product range, long-term relationships with global customers, modern and compliant manufacturing facilities, and strong R&D capabilities.
-
-
-
-
-
-
